ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 350629 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 350629; 2) Community: the network communities that were significantly associated with the response to NSC 350629; 3) Molecule: the relationships between components within communities and NSC 350629; 4) MDR: the compounds that were significantly associated with the NSC 350629.

NSC Compound Enrichment Correlation
NSC 58574 Pyrimidine, 2,4,5-trichloro-6-propyl- 0.0122129861493296 0.7318517
NSC 624191 Null 0.0122129861493296 0.52639215
NSC 625624 7,12-Epidioxybenz[a]anthracene, 7,12-dihydro-7-methyl- 0.0122129861493296 0.64402023
NSC 632573 Tris(1,3-diphenylpropane-1,3-dionata)gallium(III) 0.0122129861493296 0.26323253
NSC 664264 Null 0.0122129861493296 0.30842379
NSC 670791 Null 0.0122129861493296 0.43778299
NSC 698792 1H-Naphth[2',1':4,5]indeno[2,1-b]furan,.beta.-D-glucopyranoside derivative 0.0122129861493296 -0.25609006
NSC 704171 Null 0.0122129861493296 0.80753104
NSC 70931 2-Picenecarboxylic acid, 1,2,3,4,4a,5,6,6a,11,12b,13,14,14a,14b-tetradecahydro-10-hydroxy-2,4a,6a,9,12b,14a-hexamethyl-11-oxo- 0.0122129861493296 0.71358094
NSC 709362 Acetamide, N,N'-(1,5-pentanediyl)bis[2-(1,3,5,11a-tetrahydro- 5-oxopyrrolo[2,1-c][1,4]benzodiazepin-2-ylidene)- 0.0122129861493296 0.78198594
Total:116  Current:50    [First] [Prev] [Next] [Last]